Skip to content

Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity

Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03015103
Acronym
SAF DER ASSESS
Enrollment
28
Registered
2017-01-09
Start date
2017-01-31
Completion date
Unknown
Last updated
2017-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Irritability, Skin Sensitisation

Brief summary

The purpose of this study is to prove the product tested does not cause photoirritation or photosensitization reactions when exposed to sun light.

Interventions

DEVICEIntimate Lubrificant Gel

All the volunteers will receive the application of four dressings (3 placebos and 1 containing the tested product). After a certain period of time, photoirritation and photosensitization will be measured through the evaluation of tested region.

Sponsors

Kley Hertz S/A
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 to 70 years old; * Skin types: I (light caucasian) or III (light brown); * Intact skin where the product will be applied; * Agreement to comply with the test procedures and attend the clinic in the days and fixed times for medical assessments and application and reading of dressings * Signature of informed consent form

Exclusion criteria

* Pregnancy and lactation * Use of anti-inflammatory and immunosuppressive from 30 days up to three months prior to selection; * Diseases that cause immune suppression; * Use of photosensitizing drugs; * History or photodermatoses activities; * Personal or family history of photoinduced skin cancer; * Presence of precursor lesions of skin cancer, such as melanocytic nevi and actinic keratoses; * Intense sun exposure in the experiment area Use of new drugs and/or cosmetics during the experiment; * Previous participation in a study with the same product under test; * Relevant medical history or current evidence of alcohol or other drugs abuse; * Known historical or suspected intolerance to any ingredient of the product under study (product under test or comparator); * Sponsor's employees involved in the study, or close family member of an employee involved in the study;

Design outcomes

Primary

MeasureTime frameDescription
Photoirritation as measured through the use of dressings containing tested product and placebo5 daysThe photoirritation will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of five days.
Photosensitization as measured through the use of dressings containing tested product and placebo32 daysThe photosensitization will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product). After some hours, the region is evaluated and radiated with UVA. That procedure occurs during the period of 32 days.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026